| Returns | 1W : 1% , 1M : -0.8%,1Y : 29% |
| LT : |
Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| INDRAPRASTHA MEDICAL CORPORATION LTD | 1% | -0.8% | 29% |
| APOLLO HOSPITALS ENTERPRISE LTD | 4.5% | 16.8% | 72.5% |
| DR LAL PATHLABS LTD | -3.9% | 2.3% | 39.6% |
| FORTIS HEALTHCARE LTD | -0.6% | -2.6% | 2.7% |
| METROPOLIS HEALTHCARE LTD | -0.8% | -6% | 8.8% |
| ASTER DM HEALTHCARE LTD | -2.3% | -7.7% | -10.4% |
| NARAYANA HRUDAYALAYA LTD | -6.9% | -1.8% | 33% |
| THYROCARE TECHNOLOGIES LTD | -2% | -2.5% | 55.5% |
| SHALBY LTD | 2.8% | -3% | 19.8% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
11.18
P/E Calculated based on EPS of 4.76
[ Mar2020 - Standalone Results ] 1.82
P/B Calculated based on Book Value of 29.21
[ Mar2020 - Standalone Results ] 0.68
P/S Calculated based on Revenues of 721.29 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-2% -16% 2% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
